KGOG 3046/ TRU-D
A phase II study of neoadjuvant chemotherapy plus tremelimumab and durvalumab in advanced-stage ovarian cancer
GCGS
KGOG 3045/ AMBITION
An umbrella study of biomarker-driven targeted therapy in patients with platinum-resistant recurrent ovarian cancer
Trial Number
NCT03699449 (ClinicalTrials.gov Identifier)Contact Person
Status
Disease Site
Lead Cooperative Group
Participating Groups
GCIG Number
iPocc
IntraPeritoneal therapy for Ovarian Cancer with Carboplatin (GOTIC-001 / JGOG3019)